Nothing Special   »   [go: up one dir, main page]
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.
Schneider F, Kaczorowski A, Jurcic C, Kirchner M, Schwab C, Schütz V, Görtz M, Zschäbitz S, Jäger D, Stenzinger A, Hohenfellner M, Duensing S, Duensing A. Schneider F, et al. Among authors: duensing a. Cancers (Basel). 2023 Oct 19;15(20):5050. doi: 10.3390/cancers15205050. Cancers (Basel). 2023. PMID: 37894418 Free PMC article.
Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy.
Schoedel K, Heim T, Duensing A, Lohse I, Presutti L, Belayneh R, Bhogal S, Singh-Varma A, Chang A, Chandran U, Marker D, Szabo-Rogers H, Weiss K. Schoedel K, et al. Among authors: duensing a. Cancers (Basel). 2024 Jan 5;16(2):247. doi: 10.3390/cancers16020247. Cancers (Basel). 2024. PMID: 38254737 Free PMC article.
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.
Friedhoff J, Schneider F, Jurcic C, Endris V, Kirchner M, Sun A, Bolnavu I, Pohl L, Teroerde M, Kippenberger M, Schwab C, Kaczorowski A, Zschäbitz S, Jäger D, Hohenfellner M, Stenzinger A, Duensing A, Duensing S. Friedhoff J, et al. Among authors: duensing a, duensing s. Cancer Immunol Immunother. 2023 Jun;72(6):1603-1618. doi: 10.1007/s00262-022-03346-7. Epub 2022 Dec 23. Cancer Immunol Immunother. 2023. PMID: 36562826 Free PMC article.
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma.
Schütz V, Lin H, Kaczorowski A, Zschäbitz S, Jäger D, Stenzinger A, Duensing A, Debus J, Hohenfellner M, Duensing S. Schütz V, et al. Among authors: duensing a. Cancers (Basel). 2023 Dec 6;15(24):5715. doi: 10.3390/cancers15245715. Cancers (Basel). 2023. PMID: 38136261 Free PMC article.
PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study.
Reimold P, Tosev G, Kaczorowski A, Friedhoff J, Schwab C, Schütz V, Görtz M, Panzer N, Heller M, Aksoy C, Himmelsbach R, Walle T, Zschäbitz S, Jäger D, Duensing A, Stenzinger A, Hohenfellner M, Duensing S. Reimold P, et al. Among authors: duensing a. Diagnostics (Basel). 2024 Mar 30;14(7):741. doi: 10.3390/diagnostics14070741. Diagnostics (Basel). 2024. PMID: 38611655 Free PMC article.
PDGFRA activating mutations in gastrointestinal stromal tumors.
Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. Heinrich MC, et al. Among authors: duensing a. Science. 2003 Jan 31;299(5607):708-10. doi: 10.1126/science.1079666. Epub 2003 Jan 9. Science. 2003. PMID: 12522257
95 results